Professional Documents
Culture Documents
disorder
Surat tanprawate, MD, FRCP(T)
Neurological center
Chiangmai university
+D1recepter
Direct pathway
Indirect pathway
Neurotransmitter
• Neuroleptic drug
– Typical
– Atypical
• Non-neuroleptic drug
Neuroleptic induced movement disorder
• Acute dystonia
• Acute akathisia
• Parkinsonism
• Neuroleptic malignant syndrome
• Tardive syndrome (tardive dyskinesia)
– Buccolinguomastigatory syndrome
– Tardive stereotype
– Tardive dystonia
– Tardive tourettism
– Tardive tremor
– Tardive myoclonus
– Tardive akathisia
Neuroleptic induced acute dystonia
• Onset
– First few day
• Drug
– Neuroleptic drug (high potency)
– metoclopamide
• Risk
– Children
– Young adult
• Pathophysiology
– Sudden imbalance between striatal dopamine VS
cholinergic system
– Relative preponderance of Ach
• Clinical
– Sustained involuntary muscle contraction
– Affect various body path
• Face, jaw, tongue, neck, throat
• Sustain deviation of the eye(oculogyric crisis)
• Limb dystonia
• Air way and respiratory muscle
• Treatment
– Drug withdrawal
– Parenteral anticholinergic: Benztropine
– Anti histamine:Diphenhydramine
– Muscle relaxant (BZD) in some case
Neuroleptic induced akathisia
• Very common, very early, dose related SE
• Onset
– Few day
• Drug
– Neuroleptic (typical and atypical)
– Non-neuroleptic medication (SSRIs anti depressant)
– Dopamine receptor blockling drug
• Pathophysiology
– Not completely understood
– Complex interaction at the cortical-subcortical-
spinal level
Clinical
• Restlessness
– Wingging legs
– Pacing or rocking from foot to foot
– Stereotypies: involuntary movement that asr
coordinated patterned, repetitive
– Seemingly purposeful but actually purposeless
• Involve trunk, legs, lower face, tongue
• Treatment
– Lower dose or switching to a less potent
neuroleptic drugs
– BZP
– B-blocker
– Opiate
– clonidines
Neuroleptic induced parkinsonism
• Dopamine antagonists • CCB with dopamine
(neuroleptic, antiemetics) agonist activity
– Phenothiazine(chlorpromazine) – Flunarizine, cinnarizine
– Butyrophenone(haloperidol) • Others
– Thioxanthenes(thiothixine) – Diltiazem, captopril
– Substituted – Amiodarone, procane
benzamides(metoclopramide) – Lithium
• Dopamine depletors – Phenytoin
– Reserpine – Fluoxetine and SSRIs
– Tetrabenazine – Ara-C
– Alpha-methydopa – Amphotericin B
• Risk factor
– Female
– Older age
– Greater drug potency
– Higher dose
– Genetic predisposition
– Previous brain injury
• Clinical
– Identical to the idiopathic form
– Clinical may diff
• Symmetrical S/S
• Associated with Rabbit syndrome or tremor of
the mouth and jaw giving rise to peculiar
chewing motion
• Concurrent TD
Tardive syndrome
• Onset
– Chronic(>3 Mo. of total cumulative neuroleptic
exposure)
– Occur:
• during the course of Rx
• after dose reduction (unmask TD)
• after the causative drug has been withdrawal(covert or
withdrawal TD)
• DDx with “withdrawal dyskinesia”
– Choreotic type dyskinesia
– Children
– Acute discontinuation of neuroleptic
– Short live, spontaneous remitting
• characteristic
– Persistent, sometime irriversible abnormal
movement
– Hyperkinetic type: chorea, dystonia, tics,
myoclonus, tremor
– Usually “choreic” in type
– Unaware of TD
• Region
– Orolinguomandibular, truncal, Limb region
Pathophysiology
Long term
dopamine recepter
blockage
• Tardive dyskinesia
– Bucco-linguo-masticatory syndrome
(BLMS)
• Tardive dyskinesia varients
– Tardive dystonia
– Tardive akathisia
– Tardive myoclonus
– Tardive tics
– Tardive tremor
Bucco-linguo-masticatory syndrome
(BLMS)
• Repetitive stereotyped movement of oral and
facial movement
– Twisting and protrusion of tongue
– lip smacking and puckering and chewing
• Sometime spread to involve trunk and
extremity
• Often uninvolved the upper face
Tardive dystonia